Loading…
Saakshi Medtech and Panels (SAAKSHI)₹374.95+0.79%Other Electrical Equipment
In the Mar 2026 quarter (standalone), Saakshi Medtech and Panels reported sales of ₹56.93 Cr, up 18.8% from Mar 2025, and net profit of ₹5.99 Cr, up 505.1% year on year. For the year to Mar 2026, sales were ₹116 Cr and net profit ₹11.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 68.85 | 60.92 | 60.88 | 43.95 | 47.92 | 57.89 | 56.93 |
| Expenses | 57.06 | 52.03 | 50.06 | 38.06 | 44.05 | 48.07 | 46.02 |
| Operating Profit | 12.03 | 10.02 | 10.03 | 6.02 | 4.02 | 11.04 | 12.05 |
| OPM % | 16.9% | 15.9% | 16.9% | 14.9% | 8.0% | 18.0% | 20.0% |
| Other Income | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 1.01 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 1.01 |
| Depreciation | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 3.01 |
| Profit before tax | 9.98 | 6.99 | 7.98 | 4.98 | 1.99 | 8.98 | 7.97 |
| Tax % | 26.0% | 23.0% | 25.0% | 28.0% | 29.9% | 25.0% | 27.9% |
| Net Profit | 6.99 | 5.99 | 5.99 | 3.01 | 0.99 | 6.99 | 5.99 |
| EPS (Rs) | — | 3.15 | 3.41 | 1.96 | 0.72 | 3.77 | 3.22 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 60.93 | 59.90 | 91.90 | 122 | 122 | 91.85 | 116 |
| Expenses | 50.03 | 54.07 | 76.02 | 101 | 102 | 82.10 | 93.04 |
| Operating Profit | 11.04 | 6.02 | 16.04 | 21.05 | 20.06 | 10.04 | 22.08 |
| OPM % | 18.0% | 10.0% | 16.9% | 16.9% | 15.9% | 11.0% | 19.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.99 | 0.99 |
| Interest | 2.01 | 1.01 | 1.01 | 1.01 | 2.01 | 0.00 | 1.01 |
| Depreciation | 2.01 | 2.01 | 2.01 | 3.01 | 4.02 | 4.01 | 5.02 |
| Profit before tax | 7.98 | 2.99 | 12.95 | 16.96 | 14.96 | 6.98 | 16.94 |
| Tax % | 24.0% | 33.0% | 26.0% | 25.0% | 24.0% | 27.9% | 25.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 5.99 | 2.01 | 8.99 | 11.99 | 10.99 | 4.99 | 11.99 |
| EPS (Rs) | — | — | — | — | 6.42 | 2.68 | 6.98 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3.01 | 3.01 | 3.01 | 3.01 | 18.08 | 18.08 | 18.07 |
| Reserves | 15.00 | 17.95 | 26.98 | 39.93 | 75.97 | 80.07 | 92.95 |
| Borrowings | 18.99 | 21.97 | 15.99 | 19.99 | 17.99 | 18.02 | 24.99 |
| Other Liabilities | 11.05 | 14.07 | 19.09 | 31.15 | 19.09 | 15.07 | 21.10 |
| Total Liabilities | 48.05 | 56.00 | 65.07 | 93.08 | 131 | 131 | 157 |
| Fixed Assets | 22.07 | 22.04 | 26.08 | 34.10 | 62.21 | 60.18 | 83.16 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.05 | 10.03 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 25.98 | 33.96 | 38.99 | 58.98 | 67.92 | 58.01 | 63.92 |
| Inventories | 7.75 | 10.60 | 13.40 | 23.72 | 21.71 | 20.45 | 21.44 |
| Trade receivables | 10.42 | 14.64 | 17.43 | 22.94 | 17.27 | 21.84 | 26.19 |
| Cash & equivalents | 1.75 | 2.78 | 1.31 | 3.17 | 15.53 | 3.27 | 1.81 |
| Total Assets | 48.05 | 56.00 | 65.07 | 93.08 | 131 | 131 | 157 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | 11.02 | 0.00 | 11.02 | 11.02 | 8.02 | 3.01 | 18.04 |
| Cash from investing activity | — | −6.02 | −1.01 | −5.01 | −11.02 | −31.09 | −15.03 | −25.07 |
| Cash from financing activity | — | −2.99 | 1.99 | −6.98 | 1.99 | 35.90 | −0.99 | 5.98 |
| Net cash flow | — | 1.99 | 0.99 | −0.99 | 1.99 | 11.99 | −11.99 | −0.99 |
| Capex | 8.81 | 6.82 | 0.92 | 5.83 | 11.00 | 31.57 | 15.15 | 25.57 |
| Free cash flow | — | 4.01 | −1.01 | 5.01 | 0.00 | −24.03 | −12.02 | −8.01 |
| CFO / OP % | — | 115.1% | 28.1% | 87.1% | 73.1% | 64.1% | 50.1% | 100.1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 62 | 90 | 70 | 69 | 52 | 86 | 83 |
| Inventory days | 74 | 95 | 81 | 109 | 102 | 129 | 122 |
| Days payable | 73 | 97 | 83 | 93 | 43 | 50 | 60 |
| Cash conversion cycle | 63 | 88 | 67 | 84 | 110 | 165 | 144 |
| Working capital days | −5 | 7 | 30 | 36 | 88 | 129 | 94 |
| ROCE % | — | 11.9% | 32.0% | 32.9% | 19.0% | 6.0% | 14.0% |
For the Mar 2026 quarter, Saakshi Medtech and Panels reported sales of ₹56.93 Cr, up 18.8% year on year and net profit of ₹5.99 Cr, up 505.1% year on year. The operating margin was 20.0%.
Saakshi Medtech and Panels' sales for the year to Mar 2026 were ₹116 Cr.
Net profit for the year to Mar 2026 was ₹11.99 Cr. Earnings per share over the same trailing period were ₹6.98.
Saakshi Medtech and Panels reported borrowings of ₹24.99 Cr at Mar 2026, against cash and equivalents of ₹1.81 Cr.
Cash from operations was ₹18.04 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹8.01 Cr.